Merck beats 2Q profit forecasts, lowers guidance


The Kenilworth, New Jersey-based company said it had profit of 43 cents per share. Earnings, adjusted for costs related to mergers and acquisitions and restructuring costs, came to 93 cents per share.



from Biotech News